Results 251 to 260 of about 89,075 (280)
Some of the next articles are maybe not open access.

Cholangiocarcinoma

The Lancet, 2005
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and ...
Shahid A, Khan   +3 more
  +8 more sources

Cholangiocarcinoma

Clinics in Liver Disease, 2008
Cholangiocarcinoma is a primary hepatic malignancy originating from bile duct epithelium. It is the second most common primary hepatic neoplasia, and its incidence has increased within the last 3 decades. Although several risk factors have been identified, especially chronic biliary tract inflammation, most patients with cholangiocarcinoma have no ...
Boris R A, Blechacz, Gregory J, Gores
openaire   +2 more sources

Cholangiocarcinoma

Critical Reviews in Oncology/Hematology, 2017
Biliary tract cancer accounts for 
Michela, Squadroni   +5 more
openaire   +2 more sources

Cholangiocarcinoma

Critical Reviews in Oncology/Hematology, 2009
Cholangiocarcinoma is an uncommon adenocarcinoma with poor prognosis. Although the 1-year survival has increased over time, the 5-year survival has not shown any significant change (less than 5%). Cure can only be expected from surgical resection of early stage tumours but most patients initially present with advanced disease.
Stefania, Mosconi   +5 more
openaire   +2 more sources

Cholangiocarcinoma

Surgical Oncology Clinics of North America, 1996
Resection is indisputably associated with prolongation of survival in patients with cholangiocarcinoma and provides the only chance for cure. Equally as important is the ability to achieve microscopically clean margins at the time of resection. Liberal use of hepatic resection in conjunction with hilar vascular skeletonization may improve the ability ...
A, Marcos-Alvarez, R L, Jenkins
openaire   +2 more sources

Cholangiocarcinoma

Surgical Clinics of North America, 2019
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world. Cholangiocarcinoma arises from the malignant growth of the epithelial lining of the bile ducts and can be found all along the biliary tree.
Adeel S, Khan, Leigh Anne, Dageforde
openaire   +2 more sources

Cholangiocarcinoma

Surgical Clinics of North America
Cholangiocarcinoma (CC) is a heterogeneous group of malignancies that originates at any point along the biliary tree. CC is an uncommon malignancy as it represents approximately 3% of all gastrointestinal malignancies, though its global incidence is rising.
Matthew E, Dixon   +2 more
openaire   +4 more sources

Cholangiocarcinoma

Clinics in Liver Disease, 2001
Despite overall advances in the ability to diagnose and treat patients with cholangiocarcinoma, the prognosis for patients with this malignancy remains poor. Further improvements in the survival of patients with cholangiocarcinoma will come with the early diagnosis of these lesions.
S A, Ahrendt, A, Nakeeb, H A, Pitt
openaire   +2 more sources

Intrahepatic cholangiocarcinoma

Gastroentérologie Clinique et Biologique, 2010
Intrahepatic cholangiocarcinoma (ICC) is a primary cancer of the bile ducts, arising from malignant transformation of the epithelial cells that line the biliary apparatus. ICC is relatively uncommon, but its incidence is on the increase. ICC is frequently discovered as an incidental, indeterminate liver mass.
George A, Poultsides   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy